CD33 is expressed on plasma cells of a significant number of myeloma patients, and may represent a therapeutic target

被引：30
作者：
Robillard, N
Wuillème, S
Lodé, L
Magrangeas, F
Minvielle, S
Avet-Loiseau, H
机构：
[1] Univ Hosp, Hematol Lab, Nantes, France
[2] INSERM, U601, Nantes, France
来源：
LEUKEMIA | 2005年 / 19卷 / 11期
关键词：
D O I：
10.1038/sj.leu.2403948
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2021 / 2022
页数：2
相关论文
共 8 条
[1]   Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation [J].
Avet-Loiseau, H ;
Facon, T ;
Grosbois, B ;
Magrangeas, F ;
Rapp, MJ ;
Harousseau, JL ;
Minvielle, S ;
Bataille, R .
BLOOD, 2002, 99 (06) :2185-2191
[2]   MARKERS OF MULTIPLE HEMATOPOIETIC-CELL LINEAGES IN MULTIPLE-MYELOMA [J].
EPSTEIN, J ;
XIAO, HQ ;
HE, XY .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (10) :664-668
[3]   CHARACTERIZATION OF CD33 AS A NEW MEMBER OF THE SIALOADHESIN FAMILY OF CELLULAR INTERACTION MOLECULES [J].
FREEMAN, SD ;
KELM, S ;
BARBER, EK ;
CROCKER, PR .
BLOOD, 1995, 85 (08) :2005-2012
[4]   CD33-directed therapy with gemtuzumab ozogamicin in acute myeloid leukemia: progress in understanding cytotoxicity and potential mechanisms of drug resistance [J].
Linenberger, ML .
LEUKEMIA, 2005, 19 (02) :176-182
[5]  
Ocqueteau M, 1998, AM J PATHOL, V152, P1655
[6]  
Paul SP, 2000, BLOOD, V96, P483
[7]   CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma [J].
Robillard, N ;
Avet-Loiseau, H ;
Garand, R ;
Moreau, P ;
Pineau, D ;
Rapp, MJ ;
Harousseau, JL ;
Bataille, R .
BLOOD, 2003, 102 (03) :1070-1071
[8]   Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse [J].
Sievers, EL ;
Larson, RA ;
Stadtmauer, EA ;
Estey, E ;
Löwenberg, B ;
Dombret, H ;
Karanes, C ;
Theobald, M ;
Bennett, JM ;
Sherman, ML ;
Berger, MS ;
Eten, CB ;
Loken, MR ;
van Dongen, JJM ;
Bernstein, ID ;
Appelbaum, FR .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (13) :3244-3254
1